A Partner in Health
A new chapter, a new approach. Collaborating with physicians and other healthcare professionals, focusing on R&D and maintaining clinical leadership add up to innovative medical solutions that make a difference.
Work with Us
Join Covidien, where we appreciate your talent, your experience and your passion for your work. Our culture thrives because we invest in our colleagues' growth and reward their efforts.
Visit Us
Covidien Imaging Solutions will be at the Radiological Society of North America meeting in Chicago from November 30 – December 4, 2008. Click here to learn more about our full line of contrast media and delivery systems solutions.
COV (NYSE)
| Price: | $36.73 |
| Change: | (0.64) |
| Volume: | 2,927,288 |
Minimum 20 minute delay
-
12/23/2008 7:02:00 AM
Covidien Ltd. Announces Proposed Change in Incorporation
HAMILTON,
Bermuda --(BUSINESS WIRE)--Dec. 23, 2008 --Covidien Ltd. (NYSE: COV; BSX: COV) today announced that its Board of Directors has unanimously approved moving the Company's principal executive off... -
12/19/2008 5:31:00 AM
BOULDER, Colo., Dec 19, 2008 (BUSINESS WIRE) -- Covidien (NYSE: COV, BSX: COV), a leading global provider of healthcare products , today announced that the United States Food and Drug Administration (FDA) has issued a 510(k) marketing clearance for the Evident(TM) Microwave (... -
12/18/2008 5:31:00 AM
Covidien Launches RapidVac(TM) Smoke Evacuator
New System Minimizes Health-Risk Contaminants in the Operating Room BOULDER, Colo., Dec 18, 2008 (BUSINESS WIRE) -- Covidien (NYSE: COV, BSX: COV), a world leader in advanced energy-based surgical systems, today announced the global launch of the RapidVac(TM) S... -
12/17/2008 7:01:00 AM
Covidien Completes Transition to New and Improved Magellan Safety Needle
MANSFIELD, Mass.--(BUSINESS WIRE)--
Dec. 17, 2008 --Covidien (NYSE: COV; BSX: COV), a leading global provider of healthcare products, today confirmed the immediate availability of its new and improved Magellan(TM) Safety Hy...